Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

An AI-Based Prediction of Cognitive Capacity in Older Adults and Individuals With Mild Cognitive Impairment During Virtual Reality Driving Tasks

14 juin 2026 mis à jour par: National Cheng-Kung University Hospital

From Eye Movements to Visuomotor Coupling: An AI-Based Prediction of Cognitive Capacity in Older Adults and Individuals With Mild Cognitive Impairment During Virtual Reality Driving Tasks

Driving ability in older adults is essential for independent mobility and social participation, yet declines under high cognitive load or distraction often lead to visual attention failures such as "look-but-fail-to-see," increasing crash risk. Older adults and individuals with mild cognitive impairment (MCI) show impairments in visual attention, executive control, and visuomotor integration, which are not adequately captured by conventional assessments. Virtual reality (VR) integrated with eye-tracking and upper-limb motion analysis enables ecologically valid simulation of driving scenarios and precise quantification of visuomotor behavior. However, current studies are limited by single-scenario designs, unimodal AI models, and insufficient integration of action-related data.

This study proposes a multi-phase framework: Year 1 develops an eye-movement-based AI model for MCI identification; Year 2 integrates multimodal data in VR driving tasks; and Year 3 establishes an explainable AI system with longitudinal validation. The study aims to advance cognitive assessment and develop a digital tool for early MCI detection and driving risk prediction.

Aperçu de l'étude

Description détaillée

Driving ability in older adults is closely associated with independent mobility and social participation. However, under conditions of high cognitive load or distraction, visual attention failures-such as the "look-but-fail-to-see" phenomenon-frequently occur and substantially increase crash risk. Previous studies have demonstrated that older adults and individuals with mild cognitive impairment (MCI) exhibit declines in visual attention allocation, executive control, and visuomotor transformation efficiency. These dynamic regulatory processes are difficult to capture using conventional paper-and-pencil or static neuropsychological assessments, underscoring the need for ecologically valid and dynamic evaluation approaches.

Virtual reality (VR), when integrated with eye-tracking and upper-limb motion analysis, enables the simulation of realistic driving environments under safe and controlled conditions. This approach facilitates precise quantification of visual search behavior, hazard detection, and visuomotor coupling, thereby offering a novel framework for cognitive assessment and driving risk prediction. Despite these advances, three critical gaps remain in the current literature: (1) a lack of systematic investigations focusing on older adults and individuals with MCI across diverse VR driving scenarios to examine visual search and attentional control; (2) artificial intelligence (AI) models that are predominantly limited to single tasks or single modalities, restricting their ability to generalize across contexts; and (3) insufficient integration of upper-limb operational data to fully characterize the dynamic interactions among vision, action, and cognition.

To address these gaps, this study adopts a multi-phase, multi-level research design. In Year 1, a VR-based eye-movement system incorporating controllable cognitive load will be developed to examine pro-saccade and anti-saccade performance among young adults, cognitively healthy older adults, and individuals with MCI. This phase will establish a high-sensitivity, eye-movement-based AI model for MCI identification. In Year 2, the framework will be extended to multi-scenario VR driving tasks through the synchronous integration of eye-tracking and upper-limb operational data, enabling characterization of visuomotor coupling under varying cognitive demands. External validation, transfer learning, and multimodal fusion techniques will be applied to enhance cross-scenario generalizability. In Year 3, multimodal datasets will be integrated to develop an explainable artificial intelligence (XAI) prediction system. Longitudinal follow-up will be conducted to evaluate its prognostic validity for changes in cognitive and driving performance, ultimately leading to a clinically applicable decision-support prototype.

At the theoretical level, this study aims to elucidate the mechanisms underlying visual attention, working memory, executive control, and visuomotor coupling in older adults and individuals with MCI under dynamic conditions. At the clinical and practical levels, it seeks to develop a non-invasive and repeatable digital cognitive screening tool for early MCI detection and older-driver risk assessment, as well as to provide evidence-based support for traffic safety policy development.

Type d'étude

Observationnel

Inscription (Estimé)

192

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Taiwan
      • Tainan, Taiwan, Taïwan, 704
        • National Cheng-Kung University Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

N/A

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The study population will include healthy young adults aged 30-39 years, as well as cognitively healthy older adults and individuals with mild cognitive impairment (MCI) aged 65-85 years.

La description

Inclusion Criteria:

  • (1) a score of 23 or higher on the Montreal Cognitive Assessment; (2) a Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI); (3) healthy young adults aged between 30 and 39 years, and cognitively healthy older adults and participants with MCI aged between 65 and 85 years; (4) right-hand dominance; and (5) adequate visual function to complete VR and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.

Exclusion Criteria:

  • (1) the presence or history of major psychiatric disorders or central nervous system diseases; (2) significant ocular diseases, such as untreated cataracts, active retinal diseases, moderate-to-severe or poorly controlled glaucoma, or marked visual field deficits beyond a specified level; (3) epilepsy; and (4) severe dizziness or VR-induced motion sickness.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Young Adults
Healthy young adults (aged 30-39 years) with no history of neurological or psychiatric disorders. Participants will complete standardized virtual reality (VR) driving tasks with integrated eye-tracking and upper-limb motion recording to establish normative visuomotor and cognitive performance benchmarks.
Cognitively Healthy Older Adults
Community-dwelling older adults (≥65 years) with normal cognitive function based on standardized screening (e.g., MoCA within normal range). Participants will undergo the same VR-based assessments to examine age-related changes in visual attention, executive control, and visuomotor coupling.
Mild Cognitive Impairment (MCI)
Older adults clinically identified with mild cognitive impairment according to established diagnostic criteria. Participants will complete identical VR driving tasks to investigate alterations in visual search behavior, attentional control, and visuomotor integration, and to support development of predictive AI models for cognitive decline and driving risk.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Time to First Fixation (TFF) within the Area of Interest
Délai: Baseline
Time to First Fixation (TFF) is defined as the time interval from event onset (t₀) to the participant's first fixation within the predefined Area of Interest (AOI). A shorter TFF indicates faster attentional orienting. Units of Measure: milliseconds (ms) for each predefined AOI/event condition.
Baseline

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Number of Fixations on the Area of Interest
Délai: Baseline
Number of Fixations is defined as the total count of fixations within the predefined Area of Interest (AOI) during task performance. A higher number of fixations indicates greater visual search activity toward target stimuli. Unit of Measure: count.
Baseline
Total Fixation Duration (TFD) on the Area of Interest
Délai: Baseline
Total Fixation Duration (TFD) is defined as the cumulative fixation time within the predefined Area of Interest (AOI) during the task. Longer fixation duration indicates greater attentional engagement with the target stimulus. Unit of measure: Milliseconds.
Baseline
Steering Reaction Time
Délai: Baseline
Steering Reaction Time is defined as the interval from event onset (t₀) to the initial steering wheel deviation of ≥5°. This measure reflects motor initiation speed during driving tasks. Steering Reaction Time will be calculated separately for each driving scenario or curve type. Unit of Measure: Milliseconds (ms).
Baseline
Steering Reversal Rate (SRR)
Délai: Baseline
Steering Reversal Rate (SRR) is defined as the number of steering direction changes per minute during curve driving, using a steering-wheel angle threshold of 0.5°. Higher SRR values indicate increased steering corrections and may reflect reduced motor control stability and increased driving workload. Unit of Measure: Reversals/minute.
Baseline
Speed Change During Driving Tasks
Délai: Baseline
Speed Change is defined as the difference in average vehicle speed before and after event onset during driving tasks. This measure reflects adaptive driving behavior in response to traffic events or environmental changes, with larger changes indicating greater speed adjustment. Speed Change will be calculated separately for each driving condition. Unit of Measure: Kilometers per hour (km/h).
Baseline
Reaction Time in Speed-Limit Judgment Tasks
Délai: Baseline
Reaction Time in Speed-Limit Judgment Tasks is defined as the elapsed time between the presentation of a speed-limit stimulus and the participant's response. This measure assesses the speed of driving-related decision-making under varying cognitive demands, with longer reaction times indicating greater cognitive processing demands. Reaction time will be calculated for each task condition. Unit of Measure: Milliseconds (ms).
Baseline
Accuracy in Speed-Limit Judgment Tasks
Délai: Baseline
Accuracy in Speed-Limit Judgment Tasks is defined as the percentage of correct responses to speed-limit judgment tasks performed during driving. This measure assesses cognitive performance under dual-task conditions, with higher accuracy indicating better task performance and cognitive processing. Accuracy will be calculated for each task condition. Unit of Measure: Percentage (%).
Baseline
Standard Deviation of Lane Position (SDLP)
Délai: Baseline
Standard Deviation of Lane Position (SDLP) is defined as the variability of the vehicle's lateral lane position during driving tasks. SDLP reflects lane-keeping ability and driving stability under different driving conditions. The lower SDLP mean better driving stability. Unit of Measure: Meters (m).
Baseline
Frequency of Driving Errors
Délai: Baseline
Driving Errors are defined as the number of adverse driving events occurring during the driving task, including lane departures, collisions, and incorrect responses to secondary tasks. This measure reflects overall driving performance and safety. Error frequencies will be calculated for each driving condition, and error types will be analyzed separately. Unit of Measure: Count.
Baseline
Montreal Cognitive Assessment (MoCA) Score
Délai: Baseline
The MoCA is used to assess global cognitive function. Participants complete a standardized set of tasks covering attention, memory, language, visuospatial abilities, and executive functions. The total MoCA score reflects overall cognitive performance.Unit of Measure: Points (0-30).
Baseline
Digit Span Test Score
Délai: baseline
The Digit Span Test evaluates working memory capacity by requiring participants to recall sequences of numbers in forward and backward order. The highest correctly recalled sequence length is recorded separately for forward and backward trials. Unit of Measure: Number of digits correctly recalled.
baseline
Knox Cube Test-Revised Score
Délai: baseline
The Knox Cube Test-Revised assesses visuospatial sequential memory. Participants must replicate sequences of cube taps demonstrated by the examiner. The total number of correctly recalled sequences reflects visuospatial memory performance. Unit of Measure: Number of sequences correctly recalled.
baseline
Conners Continuous Performance Test 3 (CPT 3) Metrics
Délai: baseline
The Conners CPT 3 assesses sustained attention and inhibitory control. Primary metrics include reaction time, omission errors, commission errors, and detectability (d'). Each metric will be reported separately for each test condition. Unit of Measure: Reaction Time: milliseconds (ms); Omission Errors: count; Commission Errors: count; and Detectability (d'): unitless index.
baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

20 juin 2026

Achèvement primaire (Estimé)

31 décembre 2029

Achèvement de l'étude (Estimé)

31 décembre 2029

Dates d'inscription aux études

Première soumission

19 mai 2026

Première soumission répondant aux critères de contrôle qualité

14 juin 2026

Première publication (Réel)

18 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

14 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner